Assignee
VORONOI INC
KR·8 granted patents·12 pending applications·10 citations·filing 2020–2024
Top patents by PatentIndex Score
20 records- 0192US11466000B2Heteroaryl derivative, method for producing same, and pharmaceutical composition comprising same as effective componentVORONOI INC·Filed 2021·Granted Oct 11, 2022·5 cites·39 claims
- 0286US12037330B2Heteroaryl derivative compounds, and uses thereofVORONOI INC·Filed 2022·Granted Jul 16, 2024·4 cites·6 claims
- 0384US12157730B2Heteroaryl derivative, method for producing same, and pharmaceutical composition comprising same as effective componentVORONOI INC·Filed 2022·Granted Dec 3, 2024·1 cites·43 claims
- 0476US12534457B2Heteroaryl derivative compounds, and uses thereofVORONOI INC·Filed 2024·Granted Jan 27, 2026·0 cites·20 claims
- 0574US12528799B2Heteroaryl derivative compounds, and uses thereofVORONOI INC·Filed 2024·Granted Jan 20, 2026·0 cites·6 claims
- 0670US2024150337A1Heteroaryl derivative, method for producing same, and pharmaceutical composition comprising same as effective componentVORONOI INC·Filed 2023·Application pending·0 cites
- 0760US12152021B2Heteroaryl derivative, method for producing same, and pharmaceutical composition comprising same as effective componentVORONOI INC·Filed 2020·Granted Nov 26, 2024·0 cites·29 claims
- 0858US2024383923A1Heteroaryl derivative and use thereofVORONOI INC·Filed 2023·Application pending·0 cites
- 0956US2024067668A1Heteroaryl derivative compound and use thereofVORONOI INC·Filed 2021·Application pending·0 cites
- 1054US2024246940A1Heteroaryl derivative compound and use thereofVORONOI INC·Filed 2022·Application pending·0 cites
- 1151US2023322753A1Heteroaryl derivative, method for preparation thereof, and pharmaceutical composition comprising same as active ingredientVORONOI INC·Filed 2021·Application pending·0 cites
- 1251US2025345329A1Heteroaryl derivative compound and uses thereofVORONOI INC·Filed 2023·Application pending·0 cites
- 1350US12281121B2N-containing heteroaryl derivative and pharmaceutical composition comprising same as active ingredient for prevention or treatment of cancerVORONOI INC·Filed 2020·Granted Apr 22, 2025·0 cites·8 claims
- 1449US2025092052A1Heteroaryl derivative compounds, and uses thereofVORONOI INC·Filed 2024·Application pending·0 cites
- 1548US2025368635A1Heteroaryl derivative compound, and uses thereofVORONOI INC·Filed 2023·Application pending·0 cites
- 1646US2025019373A1Aryl or heteroaryl derivative, and pharmaceutical composition comprising same as active ingredient for prevention or treatment of kinase-related diseasesVORONOI INC·Filed 2022·Application pending·0 cites
- 1746US2024262815A1Heteroaryl derivative, method for preparing same, and pharmaceutical composition comprising same as active ingredientVORONOI INC·Filed 2022·Application pending·0 cites
- 1846US2023183243A1Heteroaryl derivatives and pharmaceutical composition comprising same as active ingredientVORONOI INC·Filed 2020·Application pending·0 cites
- 1938US2022242870A1Heterocycle-fused pyrimidine derivative and use thereofVORONOI INC·Filed 2020·Application pending·0 cites
- 2037US12240844B2Pyrrolopyridine derivative and use thereof in prevention and treatment of protein kinase-related diseaseVORONOI INC·Filed 2020·Granted Mar 4, 2025·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when VORONOI INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →